Table 3.
Serial chest X-ray manifestations of 24 deceased patients with COVID-19.
| First chest X-ray (n = 24) | Final chest X-ray (n = 24) | |
| Median (IQR) time from the chest X-ray to death, days | 8 (6–11.5) | 3 (1–3.75) |
| Distribution of lesions | ||
| Bilateral | 23 (96%) | 23 (96%) |
| Left | 0 | 0 |
| Right | 1 (4%) | 1 (4%) |
| Number of lesions | ||
| Unifocal involvement | 0 | 0 |
| Multifocal involvement | 24 (100%) | 24 (100%) |
| Number of lung fields involved | ||
| 1 | 0 | 0 |
| 2 | 0 | 0 |
| 3 | 2 (8%) | 1 (4%) |
| 4 | 4 (17%) | 1 (4%) |
| 5 | 5 (21%) | 2 (8%) |
| 6 | 13 (54%) | 20 (83%) |
| More than three lung fields involved | 24 (100%) | 24 (100%) |
| Patchy opacities | 24 (100%) | 24 (100%) |
| Round or oval solid nodules | 1 (4%) | 1 (4%) |
| Fibrous stripes | 3 (13%) | 4 (17%) |
| Pleural effusion | 3 (13%) | 7 (29%) |
| Pleural thickening | 2 (8%) | 2 (8%) |
| Pneumothorax | 0 | 3 (13%) |
| Subcutaneous emphysema | 0 | 2 (8%) |
| White lung | 0 | 6 (25%) |
| Progression of X-ray manifestations | 16/24 (67%) | |
| No significant change of X-ray manifestations | 8/24 (33%) | |
| Reduction of X-ray manifestations | 0 |